INTRODUCTION
The sympathetic nervous system, a branch of the autonomic nervous system, is critical for organ homeostasis. Postganglionic sympathetic neurons innervate a variety of peripheral targets to regulate several physiological processes, including blood glucose levels, cardiac output, and body temperature. During development, the survival and growth of sympathetic neurons rely on diffusible cues released by their targets (Glebova and Ginty, 2005) . However, whether sympathetic innervation contributes reciprocally to the morphogenesis of a target tissue remains unknown. The pancreas is a peripheral tissue that is richly innervated by adrenergic sympathetic nerves originating from the celiac and superior mesenteric ganglia (Woods and Porte, 1974) . The islets of Langerhans in the endocrine pancreas regulate blood glucose homeostasis, and islet dysfunction underlies diabetes mellitus. In adult islets, sympathetic neural activity is well known to inhibit insulin secretion and promote glucagon release to elicit an increase in circulating glucose during stress and exercise (Ahré n, 2000; Woods and Porte, 1974) . Developmentally, sympathetic innervation of the pancreas is promoted by the target-derived neurotrophin, nerve growth factor, NGF. Sympathetic innervation of the pancreas is incomplete in mice lacking NGF (Glebova and Ginty, 2004) , whereas directed overexpression of NGF in b cells results in hyperinnervation of the pancreatic islets (Edwards et al., 1989) . The onset of sympathetic innervation is coincident with stages of rapid growth, differentiation, and maturation in the embryonic pancreas (Burris and Hebrok, 2007) . Previous studies indicate that pancreatic development is dependent on instructive signals derived from neighboring tissues, including the mesenchyme and blood vessels (Golosow and Grobstein, 1962; Lammert et al., 2001) . There is also growing evidence that dysfunction of the neuronal elements in the developing pancreas might be an instigating factor in the pathogenesis of pancreatic diseases. An early loss of sympathetic fibers and glial cells in the pancreas has been observed in diabetic animal models (Mei et al., 2002; Persson-Sjö gren et al., 2005; Winer et al., 2003) . However, whether sympathetic innervation contributes to pancreatic organogenesis remains unknown.
Pancreatic islets are highly organized functional micro-organs with defined size, shape, and a distinctive arrangement of endocrine cells. Islet architecture has been postulated to underlie effective intercellular coupling, synchronized insulin release, and paracrine regulation by the islet microvasculature (BonnerWeir, 1988; Halban, 2004; Santos et al., 1991; Stagner and Samols, 1986; Valdeolmillos et al., 1989) . Although interspecies differences in islet organization have been reported (Cabrera et al., 2006; Wieczorek et al., 1998) , significant evidence suggests a unifying model that islet architecture, which optimizes cell-cell interactions between b cells, is essential in the acquisition of an adult pattern of insulin secretion (Halban et al., 1982; Konstantinova et (legend continued on next page) 2002). Perturbed islet organization is also a characteristic feature in diabetic humans and in animal models of the disease (Gepts and Lecompte, 1981; Gó mez Dumm et al., 1990; Kilimnik et al., 2011; Tokuyama et al., 1995) . In murine models, islet architecture has been shown to be established during late embryonic to early neonatal stages through a sequence of morphogenetic events, including delamination of endocrine precursors from a primordial ductal epithelium, endocrine cell migration into the surrounding mesenchyme, and clustering to form nascent islets (Puri and Hebrok, 2010) . Although a cascade of transcription factors has been identified in the regulation of pancreatic cell specification and growth, relatively little is known about the signals responsible for the coordination of endocrine cell migration and establishment of islet organization. By employing genetic and chemical ablation of sympathetic neurons in mice, we show that sympathetic innervation is necessary for establishing pancreatic islet shape and cytoarchitecture during development. Sympathectomized mice exhibit impaired glucose tolerance due to defects in glucose-stimulated insulin secretion (GSIS) later in life. Using neuron-islet cocultures, we show that sympathetic neurons promote the directed migration of b cells. We identify the nerve-derived signal as norepinephrine acting via pancreatic b-adrenergic receptors to influence islet cell migratory behavior. The effects of sympathetic deinnervation on islet architecture and glucose tolerance are recapitulated by the developmental blockade of b-adrenergic signaling. Remarkably, the pharmacological stimulation of b-adrenergic signaling during development is sufficient to restore islet morphologies and glucose metabolism in sympathectomized mice. Together, our results indicate that sympathetic neurons use noradrenergic signaling to establish the architecture of pancreatic islets and that this inductive interaction at early stages of development is critical for mature islet function in regulating glucose metabolism.
RESULTS

Sympathetic Innervation Is Necessary for Establishing Islet Architecture
To address the role of sympathetic innervation in pancreatic islet development, we visualized sympathetic nerves in the developing pancreas using immunofluorescent staining for tyrosine hydroxylase (TH), a sympathetic nerve marker, on tissue sections from MIP-GFP transgenic mice, which express GFP reporter under the insulin promoter (Hara et al., 2003) . We found that sympathetic fibers innervate the developing pancreas as early as embryonic day 14.5 (E14.5), when GFP-labeled b cells are scattered throughout the pancreas ( Figure 1A ). At E18.5, more GFP-labeled b cells are found in the vicinity of TH-positive sympathetic fibers, where they begin to form aggregates (Figure 1B) . By the first postnatal week (P6), discrete islet clusters are formed and wrapped by sympathetic fibers ( Figure 1C ). Strikingly, ablation of sympathetic innervation in neonatal mice using the neurotoxin, 6-hydroxydopamine (6-OHDA) (Kostrzewa and Jacobowitz, 1974) , resulted in a profound disorganization of islets, with the islets appearing as large streak-like aggregates instead of the characteristic globular clusters (Figures 1D and  1E ). Daily administration of 6-OHDA in newborn mice resulted in the complete loss of sympathetic innervation by P6 ( Figures  S1A and S1B) .
We further used a genetic approach to ablate sympathetic innervation. The survival and target innervation of sympathetic neurons depend on the expression of the TrkA receptor, which mediates trophic effects of the neurotrophin, NGF, secreted by target tissues (Glebova and Ginty, 2005) . We crossed mice harboring a conditional (floxed) TrkA allele (Chen et al., 2005) with mice expressing TH-driven Cre recombinase (TH-Cre) (Gong et al., 2007) . In TH-Cre;TrkA f/f mutant mice, we observed a selective depletion of TrkA protein in sympathetic neurons, whereas the expression of TrkA in islets was unaffected (Figure 1F) . Previous studies have reported that in rodents, TrkA is localized to b cells in neonatal and adult islets (Kanaka-Gantenbein et al., 1995; Miralles et al., 1998) . By the first week of birth (P6), whereas an enrichment of TH-positive sympathetic fibers was observed at the periphery of islets in control TrkA f/f animals ( Figure 1G , arrows) (Burris and Hebrok, 2007; Rodriguez-Diaz et al., 2011) , there was a complete loss of sympathetic innervation in the pancreas and several other peripheral tissues in TH-Cre;TrkA f/f mutant mice (Figures 1H and S1C-S1H). In neonatal mice, immunostaining with the islet hormone markers, insulin and glucagon, revealed that wild-type islets had coalesced into globular clusters with the stereotypical arrangement of insulin-producing b cells at the core surrounded by glucagon-producing a cells at the periphery or mantle (Figure 1I ). In contrast, in TH-Cre;TrkA f/f mutants, significant disruptions in islet cytoarchitecture were evident with islets appearing as disorganized aggregates with an intermingling of a cells and b cells within the islet core ( Figures 1J-1L ). The total number of a and b cells remained unaffected ( Figure 1M ). Despite the perturbation of islet organization in TH-Cre;TrkA f/f mice, the islets still retained a dense meshwork of microvasculature, indicating that ablation of innervation does not impair islet vascularization ( Figures 1N and 1O ). Significant disruptions in islet cytoarchitecture with mixed a cells and b cells within the islet core, in the absence of any significant changes in islet cell numbers, were also observed in the neonatal 6-OHDA-injected mice For all quantifications, n = 3 mice per genotype. Mean ± SEM. *p < 0.05, ***p < 0.001, t test. Scale bars, 50 mm. See also Figure S1 . (legend continued on next page) (Figures S1I-S1M). These results suggest that sympathetic innervation is necessary for the establishment of islet shape and cytoarchitecture. TH is also expressed in a subset of b cells in the wild-type pancreas (Teitelman and Lee, 1987) . Consistent with previous reports by Teitelman and Lee (1987) , we found 3% of insulinpositive b cells showing TH immunoreactivity in wild-type islets ( Figure S1N , arrowheads, and Figure S1P ). We noticed that there was a large increase in the number of TH-expressing b cells in TH-Cre;TrkA f/f mice ( Figures S1O and S1P ). Despite the increase in TH expression in TH-Cre;TrkA f/f mutant islets, no changes in TrkA levels were detected by immunoblotting ( Figure 1F ) or quantitative PCR analysis ( Figure S1Q ), indicating that the islet deficits observed in TH-Cre;TrkA f/f mice were not due to changes in TrkA levels in the islets themselves. Interestingly, the number of TH-positive b cells was unaffected by 6-OHDA treatment (Figures S1R-S1T).
Sympathetic Innervation Is Required for Islet Cell-Cell Contacts and Glucose-Stimulated Insulin Secretion
Given that perturbations in cytoarchitecture are associated with alterations in cell-cell interactions within islets (Jain and Lammert, 2009 ), we analyzed the expression of the major islet cell adhesion molecules: neural cell adhesion molecule (N-CAM) and E-cadherin (Dahl et al., 1996; Esni et al., 1999) Islet morphology and cytoarchitecture have been postulated to be determinants in the acquisition of functional maturity (Bosco et al., 1989; Halban et al., 1982; Hopcroft et al., 1985; Ravier et al., 2005) . We thus assessed GSIS in TH-Cre;TrkA f/f mice and wild-type littermates at 1 month of age, when islets have acquired functional maturity (Jermendy et al., 2011) . Mutant islets exhibited significant reduction in GSIS ( Figure 2I ), although they had normal insulin content ( Figure 2J ). The attenuated response of deinnervated islets to a glucose challenge suggests that sympathetic innervation during development is necessary for functional maturation of the islets. To address the mechanisms underlying deficient GSIS in deinnervated islets, we assessed aspects of glucose sensing and insulin trafficking. The b cell-specific glucose transporter, Glut2, is essential for glucose entry into b cells and activation of the glycolytic pathway that subsequently fuels insulin secretion (Thorens, 2003) . Glut2 deletion leads to severe defects in insulin secretion in mice (Guillam et al., 1997) . Although it is reported that Glut2 is not the predominantly expressed glucose transporter in human b cells (De Vos et al., 1995) , new evidence points to recessive mutations in Glut2 in patients with neonatal diabetes (Sansbury et al., 2012; Yoo et al., 2002) . TH-Cre;TrkA f/f islets exhibited reduced protein expression and surface localization of Glut2 at 1 month of age ( Figures 2K-2N ), and these deficits were evident as early as P6 ( Figures S2A-S2D ). The mutant islets also failed to secrete insulin in response to potassium chloride-mediated depolarization (Figure 2I) , suggesting defects in the mobilization of a readily releasable pool of insulin (Seino et al., 2011) . Ultrastructural analyses revealed fewer insulin granules at or very close (within 50 nm) to the plasma membrane in TH-Cre;TrkA f/f islets compared to control TrkA f/f islets ( Figures 2O-2Q ). The total number of insulin granules was not significantly different between control and mutant b cells ( Figure 2R ), consistent with the finding in Figure 2J . Together, these results indicate that the failure of mutant islets to respond to glucose arises from impaired glucose sensing and a reduction in the number of docked insulin granules. We also noticed that TH-Cre;TrkA f/f animals exhibited reductions in islet size that were only manifested by 1 month of age . The decreased islet mass in mutant animals is likely, at least in part, due to an overall reduction in body weight in mature TH-Cre;TrkA f/f animals ( Figures S2H and S2I ). The exocrine, ductal, and vascular compartments in TH-Cre;TrkA f/f pancreata all appeared normal (data not shown).
Sympathectomized Mice Are Glucose Intolerant
We then assessed metabolic parameters at the whole-animal level in TH-Cre;TrkA f/f mice. At 1 month of age, TH-Cre;TrkA f/f mice showed normal fasting blood glucose levels ( Figure S3A ) but were hyperglycemic when fed ad libitum ( Figure 3A ). Furthermore, when TH-Cre;TrkA f/f mice were challenged in a glucose tolerance test, they had significantly elevated blood glucose levels as compared to control TrkA f/f mice ( Figure 3B ). Consistent with reduced GSIS in isolated TH-Cre;TrkA f/f islets, plasma insulin levels were severely attenuated in response to the glucose challenge in TH-Cre;TrkA f/f mice ( Figure 3C ). However, the TH-Cre;TrkA f/f mice responded normally with a significant reduction in blood glucose levels when injected with insulin (R) The total number of insulin granules (per mm 2 ) is not different between mutant and control islets (n = 3 mice per genotype).
Mean ± SEM. *p < 0.05, **p < 0.01, t test. Scale bars, 50 mm (A, B, E, F, M, and N), 10 mm (C, D, G, and H), and 1 mm (O and P). See also Figure S2 .
( Figure 3D ), suggesting that the insulin sensitivity of muscle, adipose, and liver tissues is not perturbed despite the loss of sympathetic innervation. In addition, the plasma levels of other pancreatic hormones, glucagon and ghrelin, as well as that of several nonpancreatic hormones known to influence b cell biology, i.e., the gut-derived incretins (GIP and GLP-1), other gut-derived peptides (cholecystokinin, gastrin, and secretin) as well as adipose-derived leptin were all normal in TH-Cre;TrkA fl/fl mice ( Figures S3B-S3I ). Together, these findings indicate that sympathetic innervation during development is necessary for glucose homeostasis later in life and that the impaired glucose tolerance in the mutants arises primarily from islet dysfunction rather than broader physiological defects stemming from the loss of sympathetic innervation.
Sympathetic Deinnervation in Mature Animals Does Not Affect Islet Architecture and Glucose Tolerance
To determine whether sympathetic innervation is required during later postnatal stages of the development for islet architecture and glucose responsiveness, we ablated sympathetic innervation in young animals at P21 by 6-OHDA injection, after the mature organization of islets has been established. Examination of 6-OHDA-treated animals at 1.5 months of age revealed depletion of sympathetic fibers in the pancreas ( Figures 4A and 4B ). However, no defects were observed in islet architecture or in glucose tolerance of sympathectomized mice (Figures 4B and 4C) , indicating that sympathetic innervation is dispensable for the maintenance of islet architecture and glucose tolerance.
Sympathetic Neurons Promote b Cell Migration through Norepinephrine Signaling
How does sympathetic innervation influence islet formation during development? The defects in islet architecture observed in TH-Cre;TrkA f/f mice ( Figures 1E and 1J) were reminiscent of the phenotypes reported in mice where endocrine cell migration had been disrupted (Gannon et al., 2000; Kim et al., 2005; Miettinen et al., 2000) . Endocrine progenitor cells migrate away from the ducts to form mature islets. The degree of islet-duct association is a well-established criterion of endocrine cell migratory behavior during development (Miettinen et al., 2000) . The close association of islets with ducts is a feature commonly observed in neonatal mice compared to functionally mature animals. We found that 1-month-old TH-Cre;TrkA f/f mice exhibited a significantly smaller ductal-islet distance ( Figures 5A-5C ), a hallmark of reduced endocrine cell migration. We established cocultures of sympathetic neurons with fluorescently labeled b cells isolated from MIP-GFP transgenic mice and found that b cells migrated toward explants of sympathetic ganglia when cocultured in a three-dimensional Matrigel matrix, whereas b cells cultured alone exhibited little-to-no movement in the matrix over 7 days in culture ( Figures 5D-5G , S4A, and S4B). Consistent with migratory behavior, b cells in close proximity to sympathetic axons frequently exhibited polarized morphologies ( Figures 5H  and 5I ). The b cell migratory behavior was specific to the presence of sympathetic neurons because little-to-no migration was observed in the presence of either nonneuronal COS cells or sensory neurons from dorsal root ganglia (DRGs) ( Figure 5J) . A modified Sholl analysis ( Figure 5K ) to quantify the overall distribution of the b cells over the culture period revealed a gradual and directed movement of b cells toward sympathetic explants (Figures 5L and 5M) .
Sympathetic nerves innervating the pancreas release the neurotransmitter norepinephrine, which activates a-and b-adrenergic receptors (Ahré n, 2000) . Norepinephrine has been shown to influence the migration of peripheral cell types, including hematopoietic stem cells and pancreatic cancer cells (Guo et al., 2009; Katayama et al., 2006) . In the cocultures, migration of b cells toward sympathetic ganglia was significantly reduced by addition of the b-adrenergic receptor antagonist propranolol ( Figures 5N, 5J and S4C ). In contrast, the a-adrenergic antagonist phentolamine had no effect ( Figures 5J and S4D) . None of the treatments changed the total number of cultured b cells (Figure S4E ). In addition, the effects of sympathetic ganglia were specific to b cells. The ganglia explants had no effect on the migration or number of glucagon-expressing a cells in the cocultures ( Figures S4F and S4G) . These results suggest a model in which sympathetic neurons regulate islet formation during development by promoting b cell migratory behavior through noradrenergic signaling.
Developmental b-Adrenergic Signaling Regulates Islet Architecture and Glucose Metabolism
To test the hypothesis that sympathetic neurons use noradrenergic neurotransmission to regulate islet structure and function, we examined the effects of the developmental blockade of b-adrenergic signaling on islet formation and functional maturation in vivo. We administered propranolol daily to pregnant wildtype mice from late gestation (E18) and continued injections in the neonatal pups until P6. Propranolol injections did not affect islet sympathetic innervation ( Figures S5A and S5B ) but resulted in disruptions to neonatal islet architecture ( Figures 6A-6D) , which mimicked the phenotypes observed in TH-Cre;TrkA f/f pups. Additionally, when propranolol-injected animals were assessed 6 weeks after the treatment, they exhibited glucose intolerance and hyperglycemia in the fed state ( Figures 6E and 6F) . These results provide evidence that b-adrenergic blockade during the developmental window of E18-P6 impairs glucose metabolism later in life. Next, we asked whether adrenergic stimulation during development would be sufficient to restore islet morphologies and functional maturity in the sympathectomized animals. Treatment of TH-Cre;TrkA f/f mice with the b-adrenergic agonist, isoproterenol, from E18 to P6 resulted in a significant improvement in islet architecture by P6, in the absence of sympathetic innervation ( Figures 6G-6L , S5C, and S5D). Because sympathetic nerves are usually aligned with the pancreatic vasculature (Burris and Hebrok, 2007; Chiu et al., 2012) , these results imply that, despite the absence of innervation in TH-Cre;TrkA f/f mice, isoproterenol released from the islet vasculature may elicit directional migration of endocrine cells, similar to the effects of norepinephrine released from nerve terminals. Isoproterenol treatment during E18-P6 also improved glucose tolerance and significantly lowered fed blood glucose levels in TH-Cre;TrkA f/f mice, when these metabolic parameters were examined 6 weeks later ( Figures 6M  and 6N ). Sympathetic innervation, islet architecture, and glucose tolerance in control TrkA f/f animals were unaffected by the isoproterenol administration during development (Figures 6H, 6K-6N, and S5C). Together, the loss-and gain-of function analyses indicate that islet architecture and subsequent function rely on b-adrenergic signaling during development.
DISCUSSION
To date, all studies on sympathetic innervation of the pancreas have focused on the modulatory functions in adult islets during stress and exercise (Ahré n, 2000; Woods and Porte, 1974) . Here, we provide evidence for sympathetic innervation in organizing islet architecture during normal development. Furthermore, we demonstrate that this inductive interaction at early stages is critical for mature islet function in regulating glucose metabolism. It is well established that sympathetic innervation of the embryonic pancreas occurs in response to target-derived NGF, which then supports survival of innervating neurons (Glebova and Ginty, 2005) . Our findings support the model that, during development, sympathetic nerves, in turn, release norepinephrine that activates b-adrenergic signaling in migrating b cells to influence islet architecture and the acquisition of functional maturity (Figure 7 ). Similar to TH-Cre;TrkA f/f animals, b-adrenergic receptor knockout mice are glucose intolerant and have reduced insulin secretion due to perturbations in Glut2 levels when analyzed at adult stages (Asensio et al., 2005; Santulli et al., 2012) , although a detailed analysis of islet development remains to be done in these mice. Together, these findings highlight reciprocal signaling between sympathetic neurons and the pancreas that results in the codevelopment of these two physiological systems. We found that both chemical and genetic ablation of sympathetic innervation during development resulted in similar alterations in islet shape and cellular organization. In ablating sympathetic innervation, it would have been ideal to accomplish pancreas-selective deletion of sympathetic fibers. However, a potential genetic approach of pancreas-specific deletion of the sympathetic neuron survival factor, NGF, would be expected to perturb NGF signaling within the pancreas and thus affect pancreas development. Moreover, surgical lesioning of sympathetic projections to the pancreas cannot be accomplished in embryonic or neonatal pups. Despite that our approaches for deinnervation were not pancreas specific, we provided multiple lines of evidence that indicate a direct action of sympathetic innervation on islet architecture and function. First, in neuronislet cocultures, sympathetic neurons directly promote b cell migratory behavior in a manner dependent on noradrenergic signaling. Second, isolated islets from sympathectomized mice show attenuated GSIS in vitro, suggesting islet-intrinsic defects with deinnervation. Third, when injected with insulin, sympathectomized mice responded normally with a significant reduction in blood glucose levels, indicating normal insulin sensitivity in peripheral tissues despite the loss of sympathetic innervation. We did observe a difference between the genetic and chemical approaches of sympathectomy. We found an increase in the number of TH-positive b cells in TH-Cre;TrkA f/f mice, but not in 6-OHDA-treated animals. An upregulation in TH expression has been reported in functionally immature or stressed islets (Teitelman et al., 1988; Teitelman and Lee, 1987) . The reasons for TH expression in b cells and the functional consequences of increased TH-positive cells in TH-Cre;TrkA f/f islets remain unclear. To our knowledge, there are no reports of b cells synthesizing or releasing catecholamines, raising the intriguing possibility of TH functions in the pancreatic cells that are independent of catecholamine biosynthesis. It is also important to note that 6-OHDA is unlikely to have a direct effect on islets because rodent b cells, unlike human b cells, lack the dopamine reuptake transporter used by 6-OHDA (Schä fer et al., 2013) .
Our findings imply a causal relationship between the early developmental perturbations in islet architecture and the later functional deficits in sympathectomized animals. Both sympathectomy and b-adrenergic antagonism resulted in defects in islet architecture during development and glucose intolerance later in life. Importantly, the restoration of islet architecture, with b-adrenergic stimulation in sympathectomized animals, correlated with improved function. In line with previous studies implicating islet architecture in homogeneous and synchronous secretory responses, our results suggest that the disorganized islet clusters in the TH-Cre;TrkA f/f mice with the peripheral a cells interspersed among the core b cells compromise the homotypic intercellular interactions between b cells that is required for optimal insulin secretion (Halban et al., 1982; Konstantinova et al., 2007; Smolen et al., 1993) . Consistent with this notion, in deinnervated islets, we observed abnormalities in the expression and localization of N-CAM and E-cadherin that are known mediators of b cell-cell contacts and function. Similar to our observations in TH-Cre;TrkA f/f mice, N-CAM À/À mutant mice show abnormal islet architecture with intermingling of a and b cells within the islet core as well as impaired glucose tolerance in vivo (Esni et al., 1999; Olofsson et al., 2009 ). E-cadherin is necessary for b cell clustering during pancreas development and GSIS (Dahl et al., 1996; Jaques et al., 2008; Yamagata et al., 2002) . The relevance of intercellular contacts in normal b cell function is underscored by animal and human studies suggesting that perturbations in islet architecture, due to injury or disease, are closely correlated with metabolic dysfunction (Gepts and Lecompte, 1981; Gó mez Dumm et al., 1990; Kilimnik et al., 2011; Tokuyama et al., 1995) . In addition, it is recognized that, in the current translational efforts for diabetes treatment, preserving the three-dimensional arrangement of transplanted b cells could contribute to the long-term survival and optimal function of the transplants (Halban, 2004; Van Hoof et al., 2011) . It will be of interest, in future studies, to identify the signaling pathways and transcriptional programs disrupted by the loss of cell-cell contacts in the deinnervated islets. The reduced Glut2 levels and defects in docked insulin granules in TH-Cre;TrkA f/f mice suggest that the signaling pathways impinge on the glucose-sensing and insulin-trafficking machinery. Recent studies have reported that human and murine islets have distinct architecture, with the different endocrine cell types being interspersed within human islets (Brissova et al., 2005; Cabrera et al., 2006) . These findings imply that, for human islet function, heterotypic rather than homotypic cellular interactions within islets predominate. However, other findings suggest that, like rodent models, human islets also require b cell-cell contacts for efficient GSIS (Wojtusciszyn et al., 2008) . In particular, at higher glucose concentrations, homotypic contacts between human b cells were better at facilitating insulin secretion than heterotypic contacts (Wojtusciszyn et al., 2008) , pointing to a requirement for b cell-cell interactions in potentiating insulin secretion, especially under high metabolic demand. Additionally, limited studies performed on human islets at embryonic stages have reported that fetal islets are initially formed with a segregated architecture typical of murine islets, compared to the mixed architecture seen in adult human islets (Jeon et al., 2009; Piper et al., 2004) . These findings imply a significant plasticity in islet structure that may reflect the metabolic requirements at a particular stage.
Recent findings have also pointed to differences in the innervation patterns between mouse and human islets (RodriguezDiaz et al., 2011) . In human islets, sympathetic fibers do not directly contact a and b cells as in murine islets but, instead, innervate blood vessels within the islets. Thus, in human islets, sympathetic modulation of hormone release is likely due to an indirect mechanism via the release of norepinephrine into the islet vasculature or via alterations in blood flow. However, in both mice and humans, neuronal activity has similar physiological effects on inhibiting insulin and enhancing glucagon release in adult islets despite the differences in innervation patterns and architecture (Ahré n, 2000; Gilliam et al., 2007; Taborsky, 2011) . Thus, our study raises the possibility that during development, sympathetic innervation and neuronal activity may have similar effects in mice and humans in coordinating islet organization and subsequent function. In support of this prediction, we note that children with congenital insensitivity to pain with anhidrosis (CIPA), an inherited neural disorder characterized by mutations (C and D) Quantification of islet shape and endocrine cell compartmentalization in mice injected with saline or propranolol (n = 5 animals per genotype). Mean ± SEM. **p < 0.01, ***p < 0.001, t test. (E) Glucose intolerance in 1-month-old animals injected with propranolol during development (E18.5-P6), compared to vehicle-treated controls (n = 7 and 9 mice for vehicle and propranolol, respectively). Mean ± SEM. *p < 0.05, t test. (F) Developmental administration of propranolol results in elevated fed blood glucose levels in mature animals at 1.5 months (n = 7 and 9 mice for vehicle and propranolol, respectively). Mean ± SEM. **p < 0.01, t test. (G-L) Restoration of islet morphologies in neonatal TH-Cre;TrkA f/f mice treated with a b-adrenergic receptor agonist, isoproterenol, from E18 to P6. Isoproterenol administration (Iso., 30 mg/kg body weight) has no effect on islet architecture in control TrkA f/f mice (G and H) but normalizes islet structure and cytoarchitecture in Sympathetic innervation of the embryonic pancreas occurs in response to target-derived NGF, which then supports survival of innervating neurons (Glebova and Ginty, 2005) . Sympathetic nerves release norepinephrine, which acts through b-adrenergic receptors on b cells to contribute to endocrine cell migration and formation of discrete islet clusters. Nerve-dependent establishment of islet architecture is essential for intercellular contacts within islets, b cell maturation (i.e., Glut2 levels), and optimal GSIS.
in the TrkA gene, show a deficit in glucose responsiveness (Schreiber et al., 2005) , along with reduced peripheral innervation (Indo et al., 1996) , reminiscent of that seen in TH-Cre;TrkA f/f mice. It is now recognized that b cell dysfunction, inadequate insulin secretion, and impaired glucose tolerance are early hallmarks of type 2 diabetes (DeFronzo and AbdulGhani, 2011; Meece, 2007) . Although autonomic neuropathy is an established complication of diabetes (Kuehl and Stevens, 2012) , it is important to note that autonomic dysfunction in patients is already evident at the time of diagnosis of diabetes or even during a clinically normal range of blood glucose levels (Lehtinen et al., 1989; Pfeifer et al., 1984) . Indeed, epidemiological studies suggest that individuals with impaired autonomic functions are at a greater risk of developing type 2 diabetes (Carnethon et al., 2003) . Together with our findings, these studies suggest that reduced or dysfunctional sympathetic innervation of the pancreas during development may pose a risk factor for developing diabetes later in life.
) and TH-Cre mice were generous gifts from Dr. D. Ginty (JHMI) and Dr. C. Gerfen (NIH), respectively. MIP-GFP mice were obtained from Jackson Laboratory. All procedures relating to animal care and treatment conformed to institutional and NIH guidelines.
Morphometric Analyses of Islets
Ten-micrometer-thick sections of pancreata were collected every 200 mm and immunofluorescently labeled for insulin and glucagon. For cell counting, 10-20 representative sections of P6 pancreata were chosen and imaged on a Zeiss AxioImager microscope using a 203 objective. The number of a and b cells in islets was counted and divided by the number of sections to determine endocrine cell numbers. Islet circularity was determined using the ImageJ software (NIH) shape descriptors tool, calculated by the equation circularity index = 4p(area/perimeter 2 ), with ''1'' and ''0'' denoting a perfect circle and an increasingly elongated polygon, respectively. For cytoarchitecture analyses, an islet was considered to have increased a cell core localization if more than three a cells were localized to greater than two cell layers inside of the outer islet perimeter. For measurement of islet-ductal distance, 25 islets in proximity to ducts were imaged per animal. ImageJ software was used to measure the distance between the edge of the insulin-positive area and the closest adjacent duct.
In Vitro Islet Migration Assays Pancreata, superior cervical ganglia (SCGs), and DRGs were harvested from litters of 8-12 MIP-GFP mice on the day of birth. Pancreata were digested in 1 mg/ml collagenase (Type 2; Worthington Biochemical) solution in Hank's balanced salt solution (HBSS), washed with HBSS, and islets were picked under an inverted fluorescent microscope. Islets were then dissociated into single cells by gentle trituration in 4 mM EDTA in HBSS. Cell suspensions were resuspended in DMEM with 10% fetal bovine serum and 5 U/l penicillin/streptomycin (Invitrogen). To plate the cocultures, a 3 ml drop of Matrigel (BD Biosciences) was placed in the center of a collagen-coated well in a 4-well culture dish (Thermo Scientific). One SCG or DRG explant was embedded in this drop. The MIP-GFP islet cell suspension was then diluted 1:1 with Matrigel, and 10 ml of this cell suspension was plated around the central drop containing the ganglia. Culture media containing 100 ng/ml NGF were added, and the cultures were maintained for 7 days at 37 C under 10% CO 2 , with fresh media added every other day. For experiments with COS cells, a dense suspension of COS cells was mixed 1:1 with Matrigel and plated in the center of the culture dish. In experiments using adrenergic antagonists, after plating, cultures were allowed to recover overnight in culture media containing NGF alone. The next day, fresh media containing NGF and 10 mM of propranolol (Sigma-Aldrich) or phentolamine (Sigma-Aldrich) were added. Cultures were plated in duplicates or triplicates for each condition. The cultures were imaged each day with day 1 being the day after plating, using a Zeiss Axiovert microscope and a 2.53 objective. Four images were taken of each well, and the images were stitched together using Adobe Photoshop. Sholl analyses were performed using ImageJ software and the Sholl analysis plug-in (Ghosh Lab). To perform the analysis, a complete image of the culture was first subjected to a threshold to only include the GFP + cells using the same settings for each image. The analysis plug-in was then centered on the location of the ganglia, and the following plug-in parameters were used: starting radius, 10 mm; ending radius, 5,000 mm; radius step size, 10 mm; radius span, 1 mm; span type, median. The Sholl analysis plots for each well were obtained and the plots of replicate samples averaged together.
To analyze the percentage of a and b cells that migrated to the center of the cultures at the end of the experiment, the cultures were fixed in 4% PFA and immunostained with anti-glucagon, anti-GFP, or anti-b-III tubulin. After imaging, a 1 mm diameter circle was inscribed in the middle of the image centering on the ganglia, and the number of GFP + or glucagon + cells within this circle was compared to the total number of endocrine cells using ImageJ software.
Electron Microscopy
Pancreata from 1-month-old control and mutant animals were minced and fixed in buffer containing 3% formaldehyde, 1.5% glutaraldehyde, 5 mM CaCl 2 , 2.5% sucrose, and 0.1 M sodium cacodylate for 1 hr at room temperature. The tissue was postfixed in 1% Palade's OsO 4 for 1 hr on ice, followed by incubation in Kellenberger's uranyl acetate overnight at room temperature. After dehydration through graded alcohols, the tissue was embedded in Epon, and ultrathin ($90 nm) sections were collected onto EM grids. These grids were then imaged using an FEI Tecnai-12 TWIN transmission electron microscope operating at 100 kV. Three islets were chosen at random per animal, and three representative images of b cells within each islet were taken. For each image, the insulin granule density (granules/mm 2 of cytoplasm) and number of granules within 50 nm of the plasma membrane were determined using ImageJ software.
Animal studies
Glucose Tolerance and In Vivo Analysis of GSIS and Insulin Sensitivity For glucose tolerance tests, 1-to 1.5-month-old mice were fasted overnight, with a blood glucose reading the evening before the assay serving as a fed blood glucose measurement. The next morning, mice were injected intraperitoneally (i.p.) with 2 g/kg glucose (Sigma-Aldrich) dissolved in water, and blood glucose measurements were made from tail blood using a OneTouch Ultra glucometer at the indicated times (Gu et al., 2010) . For in vivo insulin secretion assays, 1-to 2-month-old mice were fasted overnight before being injected i.p. with 3 g/kg of glucose. Blood was collected from the tail at the times indicated, spun down, and the resulting plasma fraction subjected to insulin ELISA (Crystal Chem). For insulin sensitivity tests, 1-to 2-month-old mice were separated into individual cages with food the evening prior to the assay. The next morning, mice were treated with 0.75 U/kg of insulin (Novolin-R; Novo Nordisk), and blood glucose measurements were made from tail blood at the indicated times (Brü ning et al., 1997) .
Analysis of GSIS and Total Islet Insulin Content in Isolated Islets
Islets were isolated as previously described by Wollheim et al. (1990) . Briefly, following euthanasia of mice, pancreata were distended using a 0.375 mg/ml collagenase solution (Collagenase P; Roche), dissolved in HBSS (Mediatech), and digested at 37 C. The digested pancreata were then washed with HBSS and subjected to discontinuous density gradient centrifugation using different Ficoll densities (Mediatech). The islet layers were collected, washed with HBSS, and islets were handpicked under an inverted microscope for subsequent analyses. For total insulin content assays, islets were immediately lysed in acid ethanol solution, and the amount of insulin was determined by ELISA. Insulin values were normalized to islet DNA content from the same lysates using a PicoGreen kit (Invitrogen). For insulin secretion assays in isolated islets, harvested islets were allowed to recover overnight in RPMI-1640 media containing 10% fetal bovine serum and 5 U/l penicillin/streptomycin. Assays were performed in Krebs-Ringer HEPES buffer (KRBH) containing low (2.8 mM) glucose, high (25 mM) glucose, or 30 mM potassium chloride (Sigma-Aldrich). Islets were washed in lowglucose KRBH before being preincubated for 1 hr in low-glucose KRBH. After preincubation, groups of ten islets were handpicked into a 24-well plate and allowed to incubate in the conditions indicated for 1 hr. After incubation, the supernatant fraction was removed, and the islets were lysed in acid ethanol, followed by ELISA to determine the insulin concentration in both supernatant and islet fractions. Measurement of Plasma Glucagon, Ghrelin, and Nonpancreatic Hormones Tail vein blood was collected from 1-to 1.5-month-old mice in the evening prior to an overnight fast (fed ad lib sample). After fasting, a second blood sample was collected (fasted sample). Blood collected in capillary tubes was transferred to tubes containing a protease inhibitor cocktail (Roche) on ice. Samples were spun down, and the plasma fraction was acidified to 0.05 M HCl. Plasma samples were then subjected to a panel of ELISAs, following the respective manufacturer's instructions: glucagon, GLP-1, cholecystokinin, and secretin (Phoenix Pharmaceuticals); gastrin-1 (RayBiotech); GIP (total, Millipore); ghrelin (active, Millipore); and leptin (Crystal Chem). 6-OHDA Treatment Beginning on the day of birth (P0), TrkA f/f mice were injected i.p. once daily with solution as a control. Pups were sacrificed at P6 and pancreata processed for TH, insulin, and glucagon immunofluorescence. For late postnatal treatments, mice were injected beginning at P21 twice a week for 2 weeks. At 1.5 months of age, mice were subjected to glucose tolerance measurements and sacrificed to process their pancreata for immunofluorescence.
Propranolol Injections
Beginning at E18, pregnant TrkA f/f mice were injected i.p. daily with 20 mg/kg of propranolol freshly dissolved in saline or saline alone as a control. After birth, pups were injected using the same dosing scheme until P6 when they were sacrificed and pancreata processed for TH, insulin, and glucagon immunofluorescence. In parallel experiments, animals injected with propranolol or saline during E18-P6 were allowed to recover for 6 weeks, and glucose tolerance tests and blood glucose levels were assessed at 1.5 months of age.
Isoproterenol Injections
Beginning at E18, pregnant TH-Cre;TrkA f/f and control TrkA f/f mice were injected daily with 30 mg/kg of isoproterenol (Sigma-Aldrich) freshly dissolved in saline or saline alone as a control. After birth, pups were injected until P6 when they were sacrificed and pancreata processed for immunofluorescence. Isoproterenol-and saline-injected animals were also allowed to grow to adulthood (1.5 months) for glucose metabolism tests.
Statistical Analyses
All graphs and statistical analyses were done using GraphPad Prism software. Unless otherwise noted in the figure legends, statistical significance was determined using an unpaired, two-tailed Student's t test. See Extended Experimental Procedures for more information. 
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